Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
Globe Newswire•13/11/2026•08:00 ET
0
Key Highlights
- ➤Madrigal will participate in three healthcare investor conference fireside chats
- ➤Jefferies Global Healthcare Conference scheduled November 17, 2026
- ➤Evercore Healthcare Conference scheduled December 1, 2026
- ➤Piper Sandler Healthcare Conference scheduled December 2, 2026
- ➤Rezdiffra is FDA- and European Commission-approved for MASH with F2 to F3 fibrosis
CONSHOHOCKEN, Pa., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:
The fireside chats will be webcast live and can be accessed by visiting Madrigal’s Investor Relations Events page.
Get started
Create a free account to read the full story.